Insmed Incorporated INSM
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 524.43M | 425.49M | 305.96M | 263.84M | 142.34M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 524.43M | 425.49M | 305.96M | 263.84M | 142.34M |
| Cost of Revenue | 78.22M | 67.21M | 47.42M | 44.22M | 29.37M |
| Gross Profit | 446.21M | 358.27M | 258.54M | 219.62M | 112.98M |
| SG&A Expenses | 253.03M | 247.47M | 247.26M | 212.48M | 186.38M |
| Depreciation & Amortization | 5.05M | 2.08M | 2.08M | 1.94M | 1.54M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 606.26M | 526.79M | 506.25M | 513.55M | 403.69M |
| Operating Income | -81.83M | -101.31M | -200.28M | -249.71M | -261.35M |
| Income Before Tax | -97.65M | -11.37M | -162.10M | -326.93M | -368.70M |
| Income Tax Expenses | 2.67M | 1.87M | 1.47M | 1.55M | 1.32M |
| Earnings from Continuing Operations | -100.32M | -13.24M | -163.56M | -328.49M | -370.02M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -100.32M | -13.24M | -163.56M | -328.49M | -370.02M |
| EBIT | -81.83M | -101.31M | -200.28M | -249.71M | -261.35M |
| EBITDA | -73.97M | -96.58M | -195.80M | -244.68M | -257.89M |
| EPS Basic | -0.46 | -0.06 | -0.76 | -1.54 | -1.75 |
| Normalized Basic EPS | -0.26 | -0.32 | -0.61 | -0.75 | -0.78 |
| EPS Diluted | -0.46 | -0.06 | -0.76 | -1.54 | -1.75 |
| Normalized Diluted EPS | -0.26 | -0.32 | -0.61 | -0.75 | -0.78 |
| Average Basic Shares Outstanding | 218.79M | 217.35M | 215.47M | 213.64M | 211.76M |
| Average Diluted Shares Outstanding | 218.79M | 217.35M | 215.47M | 213.64M | 211.76M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |